Literature DB >> 19773419

Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).

Guillaume Canaud1, Daniel Dion, Julien Zuber, Marie-Claire Gubler, Rebecca Sberro, Eric Thervet, Renaud Snanoudj, Marina Charbit, Rémi Salomon, Frank Martinez, Christophe Legendre, Laure-Helene Noel, Patrick Niaudet.   

Abstract

UNLABELLED: Introduction. Recurrence of nephrotic-range proteinuria in patients with idiopathic nephrotic syndrome (INS) and focal and segmental glomerulosclerosis (FSGS) on native kidneys is associated with poor graft survival. Identification of risk factors for recurrence is therefore an important issue. In 2004, Columbia University introduced a histological classification of FSGS that identifies five mutually exclusive variants. In non-transplant patients, the Columbia classification appears to predict the outcome and response to treatment better than clinical characteristics alone. However, the predictive value of this classification to assess the risk of recurrence after transplantation has not been addressed.
METHODS: We retrospectively studied 77 patients with INS and FSGS on native kidneys who underwent renal transplantation. Of these, 42 recipients experienced recurrence of nephrotic range proteinuria.
RESULTS: At time of recurrence, minimal-change disease (MCD) was the main histological feature. On serial biopsies, the incidence of MCD decreased over time, while the incidence of FSGS variants increased. The variant type observed in the native kidneys was not predictive of either recurrence or type of FSGS seen on the allograft. Patients with complete and sustained remission did not developed FSGS.
CONCLUSION: In conclusion, the Columbia classification is of no help in predicting recurrence after renal transplantation or histological lesions in the case of recurrence of proteinuria.

Entities:  

Mesh:

Year:  2009        PMID: 19773419     DOI: 10.1093/ndt/gfp500

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  27 in total

1.  Circulating CD40 autoantibody and suPAR synergy drives glomerular injury.

Authors:  Changli Wei; Tara K Sigdel; Minnie M Sarwal; Jochen Reiser
Journal:  Ann Transl Med       Date:  2015-11

2.  TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.

Authors:  Martin Bitzan; Sima Babayeva; Anil Vasudevan; Paul Goodyer; Elena Torban
Journal:  Pediatr Nephrol       Date:  2012-04-27       Impact factor: 3.714

3.  Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.

Authors:  Sami Alasfar; Dany Matar; Robert A Montgomery; Niraj Desai; Bonnie Lonze; Vikas Vujjini; Michelle M Estrella; John Manllo Dieck; Gebran Khneizer; Sanja Sever; Jochen Reiser; Nada Alachkar
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

4.  Nephrotic Syndrome Post-Kidney Transplant.

Authors:  Randolph A Hennigar; Christina L Klein
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-08       Impact factor: 8.237

5.  A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Authors:  Marianne Delville; Tara K Sigdel; Changli Wei; Jing Li; Szu-Chuan Hsieh; Alessia Fornoni; George W Burke; Patrick Bruneval; Maarten Naesens; Annette Jackson; Nada Alachkar; Guillaume Canaud; Christophe Legendre; Dany Anglicheau; Jochen Reiser; Minnie M Sarwal
Journal:  Sci Transl Med       Date:  2014-10-01       Impact factor: 17.956

Review 6.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

Review 7.  Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.

Authors:  An S De Vriese; Sanjeev Sethi; Karl A Nath; Richard J Glassock; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2018-01-10       Impact factor: 10.121

Review 8.  Problems with 'focal segmental glomerulosclerosis'.

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

9.  Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis.

Authors:  Anna Francis; Peter Trnka; Steven J McTaggart
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-20       Impact factor: 8.237

Review 10.  Focal Segmental Glomerulosclerosis.

Authors:  Avi Z Rosenberg; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.